Group A Meningococcal Carriage in Travelers Returning From Saudi Arabia

JAMA: The Journal of the American Medical Association

Volumn 260, Issue 18, 1988, Pages 2686-2689

  Moore, Patrick S ^a   Harrison, Lee H ^a   Telzak, Edward E ^b   Ajello, Gloria W ^a   Broome, Claire V ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b Division of Field Services Department of Health Epidemiology Program Office ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN;

ADOLESCENT; ADULT; AGED; BACTERIUM CARRIER; CELL CULTURE; DISEASE TRANSMISSION; FATALITY; FEMALE; MAJOR CLINICAL STUDY; MALE; MENINGITIS; NEISSERIA MENINGITIDIS GROUP A; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SAUDI ARABIA; TRAVELLER DISEASE; UNITED STATES;

ADOLESCENT; ADULT; AGED; BACTERIAL VACCINES; CARRIER STATE; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; HUMAN; MALE; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL VACCINES; MIDDLE AGE; RESPIRATORY TRACT INFECTIONS; RIFAMPIN; RISK FACTORS; SAUDI ARABIA; SEASONS; TRAVEL; UNITED STATES;

EID: 0023724202     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1988.03410180094036     Document Type: Article

References (28)

1. Cochi SL, Markowitz LE, Joshi DD, et al.: Control of group A meningococcal meningitis in Nepal. Int J Epidemiol 1987;16:91-97.
2. Peltola H: Group A meningococcal polysaccharide vaccine and course of the group A meningococcal epidemic in Finland. Scand J Infect Dis 1978;10:41-44.
3. Jackson G, Lennon D, Voss L, et al.: A severe outbreak of meningococcal disease in Aukland. NZ Med J 1987;100:226.
4. Meningococcal Disease in New Delhi, India, advisory memorandum No. 79. US Public Health Service, 1985.
5. Grant FC, Sorenson K, Sow O, et al.: Epidemiological surveillance and control of cerebrospinal meningitis in Africa. WHO Chron 1973;27:347-351.
6. Greenwood BM: Selective primary health care: Strategies for control of disease in the developing world: XIII. Acute bacterial meningitis. Rev Infect Dis 1984;6:374-389.
7. Harrison LH, Broome CV: The epidemiology of meningococcal meningitis in the US civilian population, in Vedros NA (ed): The Evolution of Meningococcal Disease. Boca Raton, Fla, CRC Press, 1987, vol 1, pp 27-46.
8. Greenfield S, Sheehe PR, Feldman HA: Meningococcal carriage in a population of ’normal’ families. J Infect Dis 1971;123:67-73.
9. Broome CV: The carrier state: Neisseria meningitidis. J Antimicrob Chemother 1986;18(suppl A): 25-34.
10. Blakebrough IS, Greenwood BM, Whittle HC, et al.: The epidemiology of infections due to Neisseria meningitidis and Neisseria lactamica in a northern Nigerian community. J Infect Dis 1982; 146:626-637.
11. Novelli VM, Lewis RG, Dawood ST: Epidemic group A meningococcal disease in Hajj pilgrims. Lancet 1987;2:863.
12. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically, in Approved Standard M7-A. Villanova, Pa, National Committee for Clinical Laboratory Standards, 1985, pp 579-612.
13. Sivonen AJ: Effect of Neisseria meningitidis group A polysaccharide vaccine on nasopharyngeal carrier rates. J Infect 1981;3:266-272.
14. Meningococcal disease among travelers returning from Saudi Arabia. MMWR 1987;36:559.
15. Stephens DS, Hoffman LH, McGee ZA: Interaction of Neisseria meningitidis with human nasopharyngeal mucosa: Attachment and entry into columnar epithelial cells. J Infect Dis 1983;148: 369-376.
16. Olcen P, Kjellander J, Danielsson D, et al.: Epidemiology of Neisseria meningitidis: Prevalence and symptoms from upper respiratory tract in family members of patients with meningococcal disease. Scand J Infect Dis 1981;13:105-109.
17. Young LS, LaForce FM, Head JJ, et al.: A simultaneous outbreak of meningococcal and influenza infections. N Engl J Med 1972;287:5-9.
18. Krasinski K, Nelson JD, Butler S, et al.: Possible association of mycoplasma and viral respiratory infections with bacterial meningitis. Am J Epidemiol 1987;125:499-509.
19. Carpenter RR, Petersdorf RG: The clinical spectrum of bacterial meningitis. Am J Med 1962; 33:262-275.
20. McCormick JB, Bennett JV: Public health considerations in the management of meningococcal disease. Ann Intern Med 1975;83:883-886.
21. Jacobson JA, Filice GA, Hollaway JJ: Meningococcal disease in day care centers. Pediatrics 1977;59:299-300.
22. Jacobson JA, Moreira Carmargos PA, Ferreira JT, et al.: The risk of meningitis among class-room contacts during an epidemic of meningococcal disease. Am J Epidemiol 1976;104:552-556.
23. Hudson PJ, Vogt RL, Hean EM, et al.: Evidence for school transmission of Neisseria meningitidis during a Vermont outbreak. Pediatr Infect Dis 1986;5:213-217.
24. Gotschlich EC, Goldschneider I, Artenstein M: Human immunity to the meningococcus: V. Effect of immunization with meningococcal group C polysaccharide on the carrier state. J Exp Med 1969; 129:1385-1395.
25. Pugsley MP, Dworzack DL, Roccaforte JS, et al.: An open study of the efficacy of a single dose of ciprofloxacin in eliminating the chronic nasopharyngeal carriage of Neisseria meningitidis. J Infect Dis 1988;157:852-853.
26. Judson FN, Ehret JM: Single dose ceftriaxone to eradicate pharyngeal Neisseria meningitidis. Lancet 1984;2:1462-1463.
27. Abramson JS, Spika JS: Persistence of Neisseria meningitidis in the upper respiratory tract after intravenous antibiotic therapy for systemic meningococcal disease. J Infect Dis 1985;151: 370-371.
28. Schlech W, Ward J, Band D, et al.: Bacterial meningitis in the United States, 1978 through 1981. JAMA 1985;253:1749-1754.